Organic Letters
Letter
Ding, J.; Wu, H.; Su, W. J. Org. Chem. 2009, 74, 943−945. (g) Wu, P.-
Y.; Wu, H.-L.; Uang, B.-J. J. Org. Chem. 2006, 71, 833−835. (h) Liao,
Y.-X.; Xing, C.-H.; He, P.; Hu, Q.-S. Org. Lett. 2008, 10, 2509−2512.
(i) Duan, H.-F.; Xie, J.-H.; Shi, W.-J.; Zhang, Q.; Zhou, Q.-L. Org.
Lett. 2006, 8, 1479−1481. (j) Yamamoto, Y.; Kurihara, K.; Miyaura,
N. Angew. Chem., Int. Ed. 2009, 48, 4414−4416.
B.; Yan, X. J.; Zhu, T.; Zhao, W.; Peng, Y.; Song, S. J. J. Agric. Food
Chem. 2014, 62, 7796−7803.
(18) The absolute configuration of 2a was determined as R by
comparing the specific rotation of 2a with the reported data in ref 16a.
All of the other configurations are uncertain and based on the
assumption that the configuration follows that of 2a.
(7) (a) Moragas, T.; Correa, A.; Martin, R. Chem. - Eur. J. 2014, 20,
8242−8258. (b) Quan, L.; Lamrani, M.; Yamamoto, Y. J. Am. Chem.
Soc. 2000, 122, 4827−4828. (c) Wang, G.; Sun, S.; Mao, Y.; Xie, Z.;
Liu, L. Beilstein J. Org. Chem. 2016, 12, 2771−2775. (d) Huang, Y.-C.;
Majumdar, K. K.; Cheng, C.-H. J. Org. Chem. 2002, 67, 1682−1684.
(e) Kapoor, M.; Hwu, J. R. Sci. Rep. 2016, 6, 36225. (f) Swyka, R. A.;
Zhang, W.; Richardson, J.; Ruble, J. C.; Krische, M. J. J. Am. Chem.
Soc. 2019, 141, 1828−1832.
(8) For selected reviews, see: (a) Xiao, L.; Ye, M.-C.; Zhou, Q.-L.
Synlett 2019, 30, 361−369. (b) Weix, D. J. Acc. Chem. Res. 2015, 48,
1767−1775. (c) Standley, E. A.; Tasker, S. Z.; Jensen, K. L.; Jamison,
T. F. Acc. Chem. Res. 2015, 48, 1503−1514. (d) Jackson, E. P.; Malik,
H. A.; Sormunen, G. J.; Baxter, R. D.; Liu, P.; Wang, H.; Shareef, A.;
Montgomery, J. Acc. Chem. Res. 2015, 48, 1736−1745. For selected
recent examples, see: (e) Lv, X.-Y.; Fan, C.; Xiao, L.-J.; Xie, J.-H.;
Zhou, Q.-L. CCS Chem. 2019, 1, 328−334. (f) Ma, Y.; Cammarata, J.;
Cornella, J. J. Am. Chem. Soc. 2019, 141, 1918−1922. (g) Guo, L.;
Srimontree, W.; Zhu, C.; Maity, B.; Liu, X.; Cavallo, L.; Rueping, M.
Nat. Commun. 2019, 10, 1957. (h) Ye, Y.; Chen, H.; Sessler, J. L.;
Gong, H. J. Am. Chem. Soc. 2019, 141, 820−824. (i) Wang, W.; Ding,
C.; Li, Y.; Li, Z.; Li, Y.; Peng, L.; Yin, G. Angew. Chem., Int. Ed. 2019,
58, 4612−4616. (j) Heinz, C.; Lutz, J. P.; Simmons, E. M.; Miller, M.
M.; Ewing, W. R.; Doyle, A. G. J. Am. Chem. Soc. 2018, 140, 2292−
2300. (k) Shimkin, W.; Montgomery, J. J. Am. Chem. Soc. 2018, 140,
7074−7078. (l) Wang, Y.-X.; Qi, S.-L.; Luan, Y.-X.; Han, X.-W.;
Wang, S.; Chen, H.; Ye, M. J. Am. Chem. Soc. 2018, 140, 5360−5364.
(m) Chen, F.; Chen, K.; Zhang, Y.; He, Y.; Wang, Y.-M.; Zhu, S. J.
Am. Chem. Soc. 2017, 139, 13929−13935. (n) Wang, X.; Wang, S.;
Xue, W.; Gong, H. J. Am. Chem. Soc. 2015, 137, 11562−11565.
(o) Fu, W.; Nie, M.; Wang, A.; Tang, W. Angew. Chem., Int. Ed. 2015,
54, 2520−2524. (p) Zhao, C.; Jia, X.; Wang, X.; Gong, H. J. Am.
Chem. Soc. 2014, 136, 17645−17651.
(9) Majumdar, K. K.; Cheng, C. H. Org. Lett. 2000, 2, 2295−2298.
(10) Yurino, T.; Ueda, Y.; Shimizu, Y.; Tanaka, S.; Nishiyama, H.;
Tsurugi, H.; Sato, K.; Mashima, K. Angew. Chem., Int. Ed. 2015, 54,
14437−14441.
(11) Asachenko, A. F.; Valaeva, V. N.; Kudakina, V. A.; Uborsky, D.
V.; Izmer, V. V.; Kononovich, D. S.; Voskoboynikov, A. Z. Russ. Chem.
Bull. 2016, 65, 456−463.
(12) Garcia, K. J.; Gilbert, M. M.; Weix, D. J. J. Am. Chem. Soc. 2019,
141, 1823−1827.
(13) Ishida, S.; Suzuki, H.; Uchida, S.; Yamaguchi, E.; Itoh, A. Eur. J.
Org. Chem. 2019, 45, 7483−7487.
(14) Hu, J.-X.; Wu, H.; Li, C.-Y.; Sheng, W.-J.; Jia, Y.-X.; Gao, J.-R.
Chem. - Eur. J. 2011, 17, 5234−5237.
(15) In the preparation of this manuscript, nickel-catalyzed
intramolecular desymmetrization addition of aryl halides to 1,3-
diketones was reported, but the enantioselectivities are lower than
65% ee except for one example with 32% yield and 80% ee. See: Zhou,
(16) Nobel metal catalyzed asymmetric addition of arylboronic acids
to ketones has also been developed to prepare chiral 3-hydroxy-2,3-
dihydrobenzofurans; see: (a) Liu, G.; Lu, X. J. Am. Chem. Soc. 2006,
128, 16504−16505. (b) Zhu, D.-X.; Chen, W.-W.; Xu, M.-H.
Tetrahedron 2016, 72, 2637−2642.
(17) For the selected examples on the bioactivity of chiral 3-
hydroxyl-2,3-dihydrobenzofurans, see: (a) Thuaud, F.; Bernard, Y.;
Turkeri, G.; Dirr, R.; Aubert, G.; Cresteil, T.; Baguet, A.; Tomasetto,
C.; Svitkin, Y.; Sonenberg, N.; Nebigil, C. G.; Desaubry, L. J. Med.
Chem. 2009, 52, 5176−5187. (b) Itoigawa, M.; Itoa, C.; Tan, H. T.-
W.; Okuda, M.; Tokudad, H.; Nishino, H.; Furukawa, H. Cancer Lett.
2001, 174, 135−139. (c) Liu, Q. B.; Huang, X. X.; Bai, M.; Chang, X.
E
Org. Lett. XXXX, XXX, XXX−XXX